Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Otsuka America Pharmaceutical | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to an ongoing antidepressant trial.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Antidepressant + Aripiprazole | No Intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Antidepressant + Aripiprazole | Drug | Antidepressant Caps/Tablets Aripiprazole Tablets, Oral, 2-30mg Aripiprazole, once daily, 52-weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety assessments | throughout the study |
Not provided
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bristol-Myers Squibb | Bristol-Myers Squibb | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Local Institution | Mesa | Arizona | United States | |||
| Local Institution |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25037144 | Derived | Clayton AH, Baker RA, Sheehan JJ, Cain ZJ, Forbes RA, Marler SV, Marcus R, Berman RM, Thase ME. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study. BMC Res Notes. 2014 Jul 18;7:459. doi: 10.1186/1756-0500-7-459. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Peoria |
| Arizona |
| United States |
| Local Institution | Beverly Hills | California | United States |
| Local Institution | Burbank | California | United States |
| Local Institution | Encino | California | United States |
| Local Institution | Garden Grove | California | United States |
| Local Institution | National City | California | United States |
| Local Institution | Orange | California | United States |
| Local Institution | Pasadena | California | United States |
| Local Institution | Riverside | California | United States |
| Local Institution | San Diego | California | United States |
| Local Institution | Denver | Colorado | United States |
| Local Institution | Farmington | Connecticut | United States |
| Local Institution | Washington D.C. | District of Columbia | United States |
| Local Institution | Gainesville | Florida | United States |
| Local Institution | Jacksonville | Florida | United States |
| Local Institution | Orlando | Florida | United States |
| Local Institution | Atlanta | Georgia | United States |
| Local Institution | Smyrna | Georgia | United States |
| Local Institution | Chicago | Illinois | United States |
| Local Institution | Edwardsville | Illinois | United States |
| Local Institution | Oakbrook Terrace | Illinois | United States |
| Local Institution | Terre Haute | Indiana | United States |
| Local Institution | Overland Park | Kansas | United States |
| Local Institution | Wichita | Kansas | United States |
| Local Institution | Lexington | Kentucky | United States |
| Local Institution | Rockville | Maryland | United States |
| Local Institution | Springfield | Massachusetts | United States |
| Local Institution | Farmington Hills | Michigan | United States |
| Local Institution | Okemos | Michigan | United States |
| Local Institution | Albuquerque | New Mexico | United States |
| Local Institution | Brooklyn | New York | United States |
| Local Institution | New York | New York | United States |
| Local Institution | Staten Island | New York | United States |
| Local Institution | Chapel Hill | North Carolina | United States |
| Local Institution | Raleigh | North Carolina | United States |
| Local Institution | Cincinnati | Ohio | United States |
| Local Institution | Toledo | Ohio | United States |
| Local Institution | Portland | Oregon | United States |
| Local Institution | Philadelphia | Pennsylvania | United States |
| Local Institution | Pittsburgh | Pennsylvania | United States |
| Local Institution | East Providence | Rhode Island | United States |
| Local Institution | Charleston | South Carolina | United States |
| Local Institution | Memphis | Tennessee | United States |
| Local Institution | Austin | Texas | United States |
| Local Institution | Dallas | Texas | United States |
| Local Institution | Houston | Texas | United States |
| Local Institution | Salt Lake City | Utah | United States |
| Local Institution | Woodstock | Vermont | United States |
| Local Institution | Arlington | Virginia | United States |
| Local Institution | Charlottesville | Virginia | United States |
| Local Institution | Herndon | Virginia | United States |
| Local Institution | Richmond | Virginia | United States |
| Local Institution | Bellevue | Washington | United States |
| Local Institution | Seattle | Washington | United States |
| Local Institution | Morgantown | West Virginia | United States |
| Local Institution | Brown Deer | Wisconsin | United States |
| Local Institution | Middleton | Wisconsin | United States |
| ID | Term |
|---|---|
| D003865 | Depressive Disorder, Major |
| ID | Term |
|---|---|
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000928 | Antidepressive Agents |
| D000068180 | Aripiprazole |
| ID | Term |
|---|---|
| D011619 | Psychotropic Drugs |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D010879 | Piperazines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D015363 | Quinolones |
| D011804 | Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
Not provided
Not provided